Department of Dermatology, Yale University School of Medicine, New Haven, CA, USA.
Am J Transplant. 2011 Aug;11(8):1584-91. doi: 10.1111/j.1600-6143.2011.03645.x.
The International Transplant Skin Cancer Collaborative (ITSCC) is an organization of more than 300 members dedicated to the study and care of skin changes that develop in solid-organ transplant recipients. This group of medical and surgical dermatologists, transplant surgeons and basic science researchers was formed to better understand the basic science of transplant dermatology, and to work collaboratively to address the clinical challenges in this patient population. Transplant patients have an ∼100-fold increased risk of developing cutaneous squamous cell carcinoma than the general population and are also at an increased risk of developing basal cell carcinoma, melanoma, Merkel cell carcinoma and Kaposi's sarcoma. In October 2010, ITSCC and its European counterpart Skin Care in Organ Transplant Patients Europe (SCOPE) held a joint biennial 4-day scientific retreat in the woods near Essex, Massachusetts. In this meeting report we provide an up-to-date distillation of the novel findings presented in the 21 oral abstracts, at the tumor board and within the working groups.
国际移植皮肤癌协作组织(ITSCC)是一个由 300 多名成员组成的组织,致力于研究和护理实体器官移植受者中出现的皮肤变化。这群医学和外科皮肤科医生、移植外科医生和基础科学研究人员的成立是为了更好地了解移植皮肤科的基础科学,并共同努力应对这一患者群体的临床挑战。与普通人群相比,移植患者罹患皮肤鳞状细胞癌的风险增加了约 100 倍,罹患基底细胞癌、黑色素瘤、默克尔细胞癌和卡波西肉瘤的风险也增加了。2010 年 10 月,ITSCC 及其欧洲对应组织“器官移植患者皮肤护理欧洲”(SCOPE)在马萨诸塞州埃塞克斯附近的树林中举行了一次联合两年一度的为期 4 天的科学务虚会。在这份会议报告中,我们提供了 21 个口头摘要、肿瘤委员会和工作组中提出的新发现的最新提炼。